| Application no. and date | 13770659.4 (espacenet) (Federated) (European Patent Register), 20130923 | | Patent/reg. no. and date | DK/EP 2900269, 20180801 | | Publication date | 20150805 | | Priority no. and date | EP 12185852, 20120925 | | EP pub. no. and date |
EP 2900269 20150805 | | Effective date | | | Applicant/owner | BAYER AG,
51368 Leverkusen, DE,
Bayer Pharma Aktiengesellschaft, Müllerstrasse 178
13353 Berlin, DE | | Applicant ref. no. | Bayer BHC121029PCT-EP | | Inventor | ZIEGELBAUER, Karl, Düppelstr. 2a
42781 Haan, DE,
WEBER, Olaf, Flehenberg 28
42489 Wülfrath, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/44 (2006.01) , A61K 31/4412 (2006.01) , A61K 31/616 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , A61P 35/04 (2006.01) | | Title | KOMBINATION AF REGORAFENIB OG ACETYLSALICYLSYRE TIL BEHANDLING AF KOLOREKTAL CANCER. | | Int. application no. | EP2013069735 | | Int. publication no. | WO2014048881 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
